• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

铜催化氧化介导人低密度脂蛋白亚类中血小板活化因子(PAF)的形成。PAF乙酰水解酶在致密低密度脂蛋白中的保护作用。

Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.

作者信息

Tsoukatos D C, Arborati M, Liapikos T, Clay K L, Murphy R C, Chapman M J, Ninio E

机构信息

Department of Chemistry, University of Ioannina, Greece.

出版信息

Arterioscler Thromb Vasc Biol. 1997 Dec;17(12):3505-12. doi: 10.1161/01.atv.17.12.3505.

DOI:10.1161/01.atv.17.12.3505
PMID:9437199
Abstract

Free radical-mediated oxidation of cholesterol-rich LDL plays a key role in atherogenesis and involves the formation of oxidized phospholipids with proinflammatory biological activity. We evaluated the production of platelet-activating factor (PAF), a potent inflammatory mediator, in human LDL subspecies on copper-initiated oxidation (4 mumol/L CuCl2, 80 micrograms/mL for hours at 37 degrees C). PAF formation was determined by biological assay of HPLC-purified lipid extracts of copper-oxidized lipoproteins; chemical identity was confirmed by gas chromatographic and mass spectrometric analyses. PAF, characterized as the C16:0 molecular species, was preferentially produced in intermediate LDL (d = 1.029 to 1.039 g/mL) (8.6 +/- 5.7 pmol PAF/3 h per mg LDL protein) and light LDL (d = 1.019 to 1.029 g/mL), but was absent from dense LDL particles (d = 1.050 to 1.063 g/mL). As PAF:acetylhydrolase inactivates PAF and oxidized forms of phosphatidylcholine, we evaluated the relationship of lipoprotein-associated PAF:acetylhydrolase to PAF formation. We confirmed that PAF:acetylhydrolase activity was elevated in native, dense LDL (41.5 +/- 9.5 nmol/min per mg protein) but low in LDL subspecies of light and intermediate density (d 1.020 to 1.039 g/mL) (3.5 +/- 1.6 nmol/min per mg protein) [Tselepis et al, Arterioscler Thromb Vasc Biol. 1995;15:1764-1773]. On copper-mediated oxidation for 3 hours at 37 degrees C, dense LDL particles conserved 20 +/- 14% of their initial enzymatic activity; in contrast, PAF:acetylhydrolase activity was abolished in light and intermediate LDL subspecies. Clearly, the elevated PAF:acetylhydrolase activity of dense LDL efficiently diminishes the potential inflammatory role of endogenously formed PAF; nonetheless, formation of proatherogenic lysophospholipids results. In contrast, LDL particles of the light and intermediate subclasses can accumulate PAF on oxidative modification.

摘要

富含胆固醇的低密度脂蛋白(LDL)的自由基介导氧化在动脉粥样硬化形成中起关键作用,且涉及具有促炎生物活性的氧化磷脂的形成。我们评估了在铜引发的氧化过程(4μmol/L氯化铜,37℃下80μg/mL,持续数小时)中,人LDL亚类中血小板活化因子(PAF,一种强效炎症介质)的产生情况。通过对铜氧化脂蛋白的HPLC纯化脂质提取物进行生物学测定来确定PAF的形成;通过气相色谱和质谱分析确认化学特性。被鉴定为C16:0分子种类的PAF优先在中间密度LDL(d = 1.029至1.039 g/mL)(每毫克LDL蛋白每3小时8.6±5.7 pmol PAF)和低密度LDL(d = 1.019至1.029 g/mL)中产生,但在高密度LDL颗粒(d = 1.050至1.063 g/mL)中不存在。由于PAF:乙酰水解酶可使PAF和磷脂酰胆碱的氧化形式失活,我们评估了脂蛋白相关的PAF:乙酰水解酶与PAF形成之间的关系。我们证实,PAF:乙酰水解酶活性在天然高密度LDL中升高(每毫克蛋白41.5±9.5 nmol/分钟),但在低密度和中间密度的LDL亚类(d 1.020至1.039 g/mL)中较低(每毫克蛋白3.5±1.6 nmol/分钟)[Tselepis等人,《动脉硬化血栓与血管生物学》。1995年;15:1764 - 1773]。在37℃下铜介导氧化3小时后,高密度LDL颗粒保留了其初始酶活性的20±14%;相比之下,低密度和中间密度LDL亚类中的PAF:乙酰水解酶活性被消除。显然,高密度LDL中升高的PAF:乙酰水解酶活性有效地降低了内源性形成的PAF的潜在炎症作用;尽管如此,仍会形成促动脉粥样硬化的溶血磷脂。相比之下,低密度和中间亚类的LDL颗粒在氧化修饰时可积累PAF。

相似文献

1
Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL.铜催化氧化介导人低密度脂蛋白亚类中血小板活化因子(PAF)的形成。PAF乙酰水解酶在致密低密度脂蛋白中的保护作用。
Arterioscler Thromb Vasc Biol. 1997 Dec;17(12):3505-12. doi: 10.1161/01.atv.17.12.3505.
2
PAF-acether-degrading acetylhydrolase in plasma LDL is inactivated by copper- and cell-mediated oxidation.血浆低密度脂蛋白中血小板活化因子-乙酰水解酶可被铜介导及细胞介导的氧化作用所灭活。
Arterioscler Thromb. 1994 Mar;14(3):353-60. doi: 10.1161/01.atv.14.3.353.
3
PAF-degrading acetylhydrolase is preferentially associated with dense LDL and VHDL-1 in human plasma. Catalytic characteristics and relation to the monocyte-derived enzyme.血小板活化因子降解性乙酰水解酶在人血浆中优先与致密低密度脂蛋白和VHDL-1相关。催化特性及其与单核细胞衍生酶的关系。
Arterioscler Thromb Vasc Biol. 1995 Oct;15(10):1764-73. doi: 10.1161/01.atv.15.10.1764.
4
PAF-acetylhydrolase activity of Lp(a) before and during Cu(2+)-induced oxidative modification in vitro.体外铜离子诱导氧化修饰前后脂蛋白(a)的血小板活化因子乙酰水解酶活性
Atherosclerosis. 1996 Aug 23;125(1):121-34. doi: 10.1016/0021-9150(96)05872-8.
5
Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.人血浆低密度脂蛋白中的血小板活化因子乙酰水解酶和转乙酰酶活性
Biochem J. 2001 Jul 15;357(Pt 2):457-64. doi: 10.1042/0264-6021:3570457.
6
Dissociable and nondissociable forms of platelet-activating factor acetylhydrolase in human plasma LDL: implications for LDL oxidative susceptibility.人血浆低密度脂蛋白中血小板活化因子乙酰水解酶的可解离和不可解离形式:对低密度脂蛋白氧化易感性的影响
Biochim Biophys Acta. 1999 Jan 29;1437(1):23-36. doi: 10.1016/s0005-2760(98)00177-5.
7
Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factor.氧自由基会抑制人体血浆乙酰水解酶,该酶可分解血小板活化因子。
J Clin Invest. 1994 Jun;93(6):2408-16. doi: 10.1172/JCI117248.
8
Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated.当血小板活化因子乙酰水解酶失活时,低密度脂蛋白氧化修饰过程中血小板活化因子的形成。
Biochim Biophys Acta. 1994 Jun 2;1212(3):353-60. doi: 10.1016/0005-2760(94)90210-0.
9
Glycosylation enhances oxygen radical-induced modifications and decreases acetylhydrolase activity of human low density lipoprotein.糖基化增强氧自由基诱导的修饰作用,并降低人低密度脂蛋白的乙酰水解酶活性。
Basic Res Cardiol. 1997 Apr;92(2):96-105. doi: 10.1007/BF00805570.
10
Increased activity of platelet-activating factor acetylhydrolase in low-density lipoprotein subfractions induces enhanced lysophosphatidylcholine production during oxidation in patients with heterozygous familial hypercholesterolaemia.在杂合子家族性高胆固醇血症患者中,低密度脂蛋白亚组分中血小板活化因子乙酰水解酶活性增加,导致氧化过程中溶血磷脂酰胆碱生成增强。
Eur J Clin Invest. 1997 Jul;27(7):595-602. doi: 10.1046/j.1365-2362.1997.1570706.x.

引用本文的文献

1
Circulating biologically active oxidized phospholipids show on-going and increased oxidative stress in older male mice.循环中的具有生物活性的氧化磷脂表明老年雄性小鼠存在持续且增加的氧化应激。
Redox Biol. 2013;1(1):110-4. doi: 10.1016/j.redox.2012.11.011. Epub 2013 Jan 30.
2
To hydrolyze or not to hydrolyze: the dilemma of platelet-activating factor acetylhydrolase.水解还是不水解:血小板活化因子乙酰水解酶的困境
J Lipid Res. 2014 Sep;55(9):1847-54. doi: 10.1194/jlr.R045492. Epub 2014 May 23.
3
Inhibition of oxidative stress and lipid peroxidation by anthocyanins from defatted Canarium odontophyllum pericarp and peel using in vitro bioassays.
利用体外生物测定法研究脱脂毛叶橄榄果皮和果壳中的花青素对氧化应激和脂质过氧化的抑制作用。
PLoS One. 2014 Jan 9;9(1):e81447. doi: 10.1371/journal.pone.0081447. eCollection 2014.
4
Bioactive oxidatively truncated phospholipids in inflammation and apoptosis: formation, targets, and inactivation.炎症与细胞凋亡中的生物活性氧化截短磷脂:形成、靶点及失活
Biochim Biophys Acta. 2012 Oct;1818(10):2456-64. doi: 10.1016/j.bbamem.2012.03.004. Epub 2012 Mar 16.
5
Platelet activation by low concentrations of intact oxidized LDL particles involves the PAF receptor.低浓度完整氧化低密度脂蛋白颗粒引起的血小板活化涉及血小板活化因子受体。
Arterioscler Thromb Vasc Biol. 2009 Mar;29(3):363-71. doi: 10.1161/ATVBAHA.108.178731. Epub 2008 Dec 26.
6
Platelet-activating factor acetylhydrolase and transacetylase activities in human aorta and mammary artery.人主动脉和乳腺动脉中的血小板活化因子乙酰水解酶及转乙酰酶活性
J Lipid Res. 2008 Oct;49(10):2240-9. doi: 10.1194/jlr.M800188-JLR200. Epub 2008 Jun 27.
7
Platelet-activating factor acetylhydrolase and transacetylase activities in human plasma low-density lipoprotein.人血浆低密度脂蛋白中的血小板活化因子乙酰水解酶和转乙酰酶活性
Biochem J. 2001 Jul 15;357(Pt 2):457-64. doi: 10.1042/0264-6021:3570457.
8
Oxidized low-density lipoprotein and peroxisome-proliferator-activated receptor alpha down-regulate platelet-activating-factor receptor expression in human macrophages.氧化型低密度脂蛋白和过氧化物酶体增殖物激活受体α下调人巨噬细胞中血小板活化因子受体的表达。
Biochem J. 2001 Feb 15;354(Pt 1):225-32. doi: 10.1042/0264-6021:3540225.